Evidence map›Paper›PMID 32904427›Full record

Observational studyCell reports. Medicine2020

Microbiota Supplementation with

Cristina Alcon-Giner, Matthew J Dalby, Shabhonam Caim, Jennifer Ketskemety, Alex Shaw, Kathleen Sim, Melissa A E Lawson, Raymond Kiu, Charlotte Leclaire, Lisa Chalklen and 9 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Cell reports. Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 6 pooled it
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 6 syntheses or guidelines pooled it, 232 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Efficacy ofFrontiers in nutrition · 2026
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Effects ofCell reports. Medicine · 2021
    Trial
  15. Review
  16. Priming innate immunity and long-term outcome.Molecular and cellular pediatrics · 2026
    Review
  17. Article
  18. Review
  19. Review
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Cristina Alcon-GinerGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Matthew J DalbyGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Shabhonam CaimGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Jennifer KetskemetyGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Alex ShawDepartment of Medicine, Section of Pediatrics, Imperial College London, London, UK.
Kathleen SimDepartment of Medicine, Section of Pediatrics, Imperial College London, London, UK.
Melissa A E LawsonGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Raymond KiuGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Charlotte LeclaireGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Lisa ChalklenGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Magdalena KujawskaGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Suparna MitraGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Fahmina Fardus-ReidDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
Gustav BeltekiNeonatal Intensive Care Unit, The Rosie Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Katherine McCollNeonatal Intensive Care Unit, Norfolk and Norwich University Hospital, Norwich, UK.
Jonathan R SwannDepartment of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
J Simon KrollDepartment of Medicine, Section of Pediatrics, Imperial College London, London, UK.
Paul ClarkeNeonatal Intensive Care Unit, Norfolk and Norwich University Hospital, Norwich, UK.
Lindsay J HallGut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Norwich Research Park · GBImperial College London · GBUniversity of East Anglia · GBNorfolk and Norwich University Hospital · GBRosie Hospital · GBUniversity of Leeds · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/F/00044409Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10353Biotechnology and Biological Sciences Research Council BBS/E/F/000PR10356Wellcome Trust
6 · The paper itself

Abstract

Supplementation with members of the early-life microbiota as "probiotics" is increasingly used in attempts to beneficially manipulate the preterm infant gut microbiota. We performed a large observational longitudinal study comprising two preterm groups: 101 infants orally supplemented with

Indexed as

BifidobacteriumBreast FeedingDietary SupplementsFecesGastrointestinal MicrobiomeHumansInfantInfant, NewbornInfant, PrematureLactobacillusLongitudinal StudiesMetabolomeMilk, HumanProbioticsRNA, Ribosomal, 16SRNA, Ribosomal, 16SBifidobacteriumhuman milk oligosaccharidesLactobacillusmetabolitesmicrobiotapathobiontspHpreterm infantprobioticsupplementation

Identifiers

PMID32904427
PMCPMC7453906
OpenAlexW3080773717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.